- Home
- BLDEW vs SOAR Comparison
BLDEW vs SOAR Comparison
Compare BLDEW & SOAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLDEW
- SOAR
- Stock Information
- Founded
- BLDEW 2014
- SOAR 2021
- Country
- BLDEW United States
- SOAR United States
- Employees
- BLDEW 322
- SOAR N/A
- Industry
- BLDEW Transportation Services
- SOAR Blank Checks
- Sector
- BLDEW Consumer Discretionary
- SOAR Finance
- Exchange
- BLDEW Nasdaq
- SOAR Nasdaq
- Market Cap
- BLDEW N/A
- SOAR N/A
- IPO Year
- BLDEW N/A
- SOAR N/A
- Fundamental
- Price
- BLDEW $0.24
- SOAR $1.31
- Analyst Decision
- BLDEW
- SOAR
- Analyst Count
- BLDEW 0
- SOAR 0
- Target Price
- BLDEW N/A
- SOAR N/A
- AVG Volume (30 Days)
- BLDEW 51.0K
- SOAR 3.6M
- Earning Date
- BLDEW 03-13-2025
- SOAR 08-13-2025
- Dividend Yield
- BLDEW N/A
- SOAR N/A
- EPS Growth
- BLDEW N/A
- SOAR N/A
- EPS
- BLDEW N/A
- SOAR N/A
- Revenue
- BLDEW $241,814,000.00
- SOAR $71,723,000.00
- Revenue This Year
- BLDEW N/A
- SOAR N/A
- Revenue Next Year
- BLDEW N/A
- SOAR N/A
- P/E Ratio
- BLDEW N/A
- SOAR N/A
- Revenue Growth
- BLDEW 12.04
- SOAR 259.41
- 52 Week Low
- BLDEW $0.30
- SOAR $1.14
- 52 Week High
- BLDEW $0.36
- SOAR $21.49
- Technical
- Relative Strength Index (RSI)
- BLDEW N/A
- SOAR 32.43
- Support Level
- BLDEW N/A
- SOAR $1.14
- Resistance Level
- BLDEW N/A
- SOAR $1.68
- Average True Range (ATR)
- BLDEW 0.00
- SOAR 0.15
- MACD
- BLDEW 0.00
- SOAR -0.03
- Stochastic Oscillator
- BLDEW 0.00
- SOAR 19.10
About BLDEW Blade Air Mobility Inc.
Blade Air Mobility Inc is a technology-powered air mobility platform that provides air transportation and logistics for hospitals and is a transporter of human organs for transplant, and for passengers, with helicopter and fixed-wing services predominantly in the Northeast United States, Southern Europe and Western Canada. The company's operating segments are; Passenger, and Medical. Majority of the revenue for the company is generated from its Medical segment which predominantly consists of transportation of human organs for transplant and the medical teams supporting these services. It also offers additional services including donor logistics coordination and support in evaluating potential donor organs. A substantial portion of the company's revenue is generated from the United States.